Cargando…

Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition

Although optimal therapy for myocardial infarction includes reperfusion to restore blood flow to the ischemic region, ischemia/reperfusion (IR) also initiates an inflammatory response likely contributing to adverse left ventricular (LV) extracellular matrix (ECM) remodeling. Galectin-3 (Gal-3), a β-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibarrola, Jaime, Matilla, Lara, Martínez-Martínez, Ernesto, Gueret, Alexandre, Fernández-Celis, Amaya, Henry, Jean-Paul, Nicol, Lionel, Jaisser, Frederic, Mulder, Paul, Ouvrard-Pascaud, Antoine, López-Andrés, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610618/ https://www.ncbi.nlm.nih.gov/pubmed/31270370 http://dx.doi.org/10.1038/s41598-019-46119-6

Ejemplares similares

Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models
por: Bonnard, Benjamin, et al.
Publicado: (2021)

Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage
por: Martinez-Martinez, Ernesto, et al.
Publicado: (2016)

Role for Galectin‐3 in Calcific Aortic Valve Stenosis
por: Sádaba, J. Rafael, et al.
Publicado: (2016)

Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice
por: Pieronne‐Deperrois, Marie, et al.
Publicado: (2021)

Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts
por: Martínez-Martínez, Ernesto, et al.
Publicado: (2017)

Beneficial Effects of Mineralocorticoid Receptor Antagonism on Myocardial Fibrosis in an Experimental Model of the Myxomatous Degeneration of the Mitral Valve
por: Ibarrola, Jaime, et al.
Publicado: (2020)

Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model
por: Ibarrola, Jaime, et al.
Publicado: (2017)

Sex-specific role of galectin-3 in aortic stenosis
por: Matilla, Lara, et al.
Publicado: (2023)

Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein
por: Jover, Eva, et al.
Publicado: (2021)

Aldosterone Impairs Mitochondrial Function in Human Cardiac Fibroblasts via A-Kinase Anchor Protein 12
por: Ibarrola, Jaime, et al.
Publicado: (2018)

The Absence of Endothelial Sodium Channel α (αENaC) Reduces Renal Ischemia/Reperfusion Injury
por: Tarjus, Antoine, et al.
Publicado: (2019)

Aldosterone Promotes Cardiac Endothelial Cell Proliferation In Vivo
por: Gravez, Basile, et al.
Publicado: (2015)

The protective function of galectin‐9 in liver ischemia and reperfusion injury in mice
por: Hirao, Hirofumi, et al.
Publicado: (2015)

Transient heart rate reduction improves acute decompensated heart failure‐induced left ventricular and coronary dysfunction
por: Peschanski, Nicolas, et al.
Publicado: (2021)

Pharmacological treatment with galectin-1 protects against renal ischaemia-reperfusion injury
por: Carlos, Carla P., et al.
Publicado: (2018)

Pharmacology of Catechins in Ischemia-Reperfusion Injury of the Heart
por: Ferenczyová, Kristína, et al.
Publicado: (2021)

Galectin-1 alleviates myocardial ischemia-reperfusion injury by reducing the inflammation and apoptosis of cardiomyocytes
por: Ou, Dengke, et al.
Publicado: (2022)

Sex-dependent expression of neutrophil gelatinase-associated lipocalin in aortic stenosis
por: Jover, Eva, et al.
Publicado: (2022)

Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies
por: Soares, Ricardo O. S., et al.
Publicado: (2019)

Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease
por: Garcia-Pena, Amaia, et al.
Publicado: (2021)

Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction
por: Lima-Posada, Ixchel, et al.
Publicado: (2023)

Effects of warm ischemia and reperfusion on the liver microcirculatory phenotype of rats: underlying mechanisms and pharmacological therapy
por: Hide, Diana, et al.
Publicado: (2016)

Galectin-3 as TREM2 upstream factor contributes to lung ischemia-reperfusion injury by regulating macrophage polarization
por: Liu, Hao, et al.
Publicado: (2023)

Innovative Pharmacological/Therapeutic Approaches against Hepatic Ischemia/Reperfusion Injury
por: Vairetti, Mariapia, et al.
Publicado: (2015)

Pharmacological properties and mechanisms of Notoginsenoside R1 in ischemia-reperfusion injury
por: Zhu, Ting, et al.
Publicado: (2023)

Alternative Interventions to Prevent Oxidative Damage following Ischemia/Reperfusion
por: Rodríguez-Lara, Simón Quetzalcoatl, et al.
Publicado: (2016)

Protein Alterations in Cardiac Ischemia/Reperfusion Revealed by Spatial-Omics
por: Mezger, Stephanie T. P., et al.
Publicado: (2022)

Pharmacological postconditioning with diazoxide attenuates ischemia/reperfusion-induced injury in rat liver
por: TIAN, Y.S., et al.
Publicado: (2013)

Strategies for Pharmacological Organoprotection during Extracorporeal Circulation Targeting Ischemia-Reperfusion Injury
por: Salameh, Aida, et al.
Publicado: (2015)

Pharmacological Inhibition of S-Nitrosoglutathione Reductase Reduces Cardiac Damage Induced by Ischemia–Reperfusion
por: Castillo, Oscar Arriagada, et al.
Publicado: (2021)

Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure
por: Heron, Coraline, et al.
Publicado: (2022)

Effect of Telmisartan in the Oxidative Stress Components Induced by Ischemia Reperfusion in Rats
por: Rodríguez-Lara, Simón Quetzalcoatl, et al.
Publicado: (2019)

Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury
por: Nakamura, Toshifumi, et al.
Publicado: (2022)

Cardioprotective effects of pharmacological blockade of the mitochondrial calcium uniporter on myocardial ischemia-reperfusion injury
por: Menezes-Rodrigues, Francisco Sandro, et al.
Publicado: (2020)

Network Pharmacology-Based Exploration of the Therapeutic Mechanisms of Cordyceps cicadae in Renal Ischemia/Reperfusion
por: Dong, Jiajun, et al.
Publicado: (2022)

Pharmacological Cardioprotection against Ischemia Reperfusion Injury—The Search for a Clinical Effective Therapy
por: Wang, Qian, et al.
Publicado: (2023)

Soluble St2 Induces Cardiac Fibroblast Activation and Collagen Synthesis via Neuropilin-1
por: Matilla, Lara, et al.
Publicado: (2020)

Multi-faceted roles of cathepsins in ischemia reperfusion injury (Review)
por: Huertas, Jaime, et al.
Publicado: (2022)

Pharmacological evaluation of tacrolimus (FK-506) on ischemia reperfusion induced vasculatic neuropathic pain in rats
por: Muthuraman, Arunachalam, et al.
Publicado: (2010)

Pharmacologic targeting of renal ischemia-reperfusion injury using a normothermic machine perfusion platform
por: Hameed, Ahmer M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dj95iojqsf42th6abtlkp69ddd